Valvoline Gears Up for IPO in Most Recent Filing
Valvoline has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
All Work
Chris Lange
Shire Gains Key FDA Approval in Dry Eye Treatment
Shire made waves Tuesday morning following a key FDA approval of its eye drop solution indicated for the treatment of the signs and symptoms of dry eye disease in adult patients.
Protagonist Therapeutics Files for IPO
Protagonist Therapeutics has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
Biotechs With Drug Pipelines Closest to Zero Valuation
Credit Suisse has taken a look at which biotech companies in its coverage have the least credit given to pipeline potential at current levels.
Sage Therapeutics Scores Huge Win in Depression Trial
Sage Therapeutics blew out expectations early on Tuesday morning after the company released results from its mid-stage depression trial.
Alcoa Beats Earnings Ahead of the Split
Alcoa Inc. (NYSE: AA) reported second-quarter financial results after the markets closed on Monday. The company said that it had $0.15 in earnings per share (EPS) on $5.3 billion in revenue. Thomson Reuters had…
Talend Announces Possible Pricing for IPO
Talend expects to price more than 5 million American depositary shares in the range of $15 to $17 per share in an initial public offering valued up to more than $102 million.
Patheon Prepares for IPO With Updated Pricing Details
Patheon expects to price more than 30 million shares in the range of $19 to $22 per share for a initial public offering valued up to about $771 million.
Impinj Updates IPO With New Pricing Details
Impinj expects to price more than 4 million shares in the range of $12 to $14 per share for an initial public offering valued up to about $74 million.
Audentes Gears Up for IPO With Updated Pricing
Audentes Therapeutics expects to price its 5 million shares in the range of $14 to $16, for an initial public offering valued up to $92 million.
TPI Announces Potential Pricing for IPO
TPI Composites expects to price more than 7 million shares in the range of $15 to $17 per share for an initial public offering valued up to more than $141 million.
First Hawaiian Prepares for IPO
First Hawaiian has filed an S-1 form with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO). No pricing details were listed in the filing, but the offering is valued up to…
Forterra Gears Up for IPO
Forterra has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
CBS Radio Files for IPO
CBS Radio has filed with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).
What to Expect From Alcoa Earnings
Alcoa is scheduled to report its second-quarter financial results after the markets close on Monday.
Top 5 Earnings for the Week Ahead
24/7 Wall St. has put together a preview of Alcoa, Citigroup and some other major companies reporting their quarterly results this week.
3 Companies That Destroyed Shareholders This Past Week
24/7 Wall Street has picked out a few companies posting the largest losses last week, including Humana.
Why Analysts Are More Bullish About Pepsi After Earnings
When PepsiCo reported second-quarter 2016 results on Thursday, overall the response was fairly positive.
How Badly Analysts Ditched Juno Therapeutics After Clinical Hold
Juno Therapeutics saw its shares sink on Friday after the U.S. Food and Drug Administration levied a clinical hold on its leukemia treatment.
WD-40 Posts Solid Earnings and Guidance
WD-40 reported better-than-expected fiscal third-quarter financial results after the markets closed on Thursday.